• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CMB 0.00% 40.0¢

CAMBIUM BIO LIMITED - Announcements

Cambium Bio Limited, formerly Regeneus Ltd, is an Australia-based clinical-stage... Cambium Bio Limited, formerly Regeneus Ltd, is an Australia-based clinical-stage regenerative medicine company focusing on the development of biologics for ophthalmology and tissue repair applications. Its technology, based on human platelet lysate, is being leveraged to create a pipeline of novel therapeutics, with a primary focus on ophthalmology. Its lead product candidate, Elate Ocular, is being developed to address significant unmet medical needs in the treatment of dry eye disease. Elate Ocular is formulated from the processing of base human platelets sourced not from patients, but generally healthier younger eligible donors at U.S. blood collection centers. In addition, its stem cell platform, Progenza, is being applied to the development of therapies for knee osteoarthritis and other tissue repair indications. It also manufactures and sells stem cell growth supplements, such as UltraGRO Advanced, UltraGRO Pure (xeno-free), and UltraGRO Pure GI (xeno-free, gamma irradiated).More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Announcements


CMB Investor Update Webcast - November 202105/11/21 download Created with Sketch. 119.87KB
CMB Amendment to Institutional Placement05/11/21 download Created with Sketch. 138.3KB
CMB Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE29/10/21 download Created with Sketch. 372.82KB
CMB Regeneus Corporate Presentation (October 2021)28/10/21 download Created with Sketch. 1.31MB
CMB Revised Securities Trading Policy26/10/21 download Created with Sketch. 225.84KB
CMB Appendix 4G and Corporate Governance Statement26/10/21 download Created with Sketch. 399.5KB
CMB Annual Report 202126/10/21 download Created with Sketch. 6.56MB
CMB Regeneus Company Update Investor Webcast Presentation25/10/21 download Created with Sketch. 136.6KB
CMB Virtual Annual General Meeting Online Guide15/10/21 download Created with Sketch. 1.55MB
CMB Notice of Annual General Meeting / Proxy / Question Form15/10/21 download Created with Sketch. 616.21KB
CMB Application for quotation of securities - RGS14/10/21 download Created with Sketch. 24.88KB
CMB Cleansing Statement14/10/21 download Created with Sketch. 681.1KB
CMB Revised Date of AGM20/09/21 download Created with Sketch. 431.22KB
CMB Appendix 4E - Preliminary final report-unauditedPRICE SENSITIVE31/08/21 download Created with Sketch. 1.04MB
CMB Date of AGM19/08/21 download Created with Sketch. 432.71KB
CMB Lapse of Unlisted Share Options - correction09/08/21 download Created with Sketch. 553.51KB
CMB Notification of cessation of securities - RGS09/08/21 download Created with Sketch. 21.54KB
CMB Lapse of Unlisted Share Options09/08/21 download Created with Sketch. 124.15KB
CMB Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE29/07/21 download Created with Sketch. 320.85KB
CMB R&D Collaboration with Kolling Institute28/07/21 download Created with Sketch. 309.42KB
CMB Company Secretary Appointment/Resignation30/06/21 download Created with Sketch. 120.07KB
CMB Appendix 2A12/05/21 download Created with Sketch. 205.47KB
CMB Cleansing Statement12/05/21 download Created with Sketch. 95.4KB
CMB Proposed issue of Securities - RGS07/05/21 download Created with Sketch. 32.58KB
CMB Regeneus Announces Institutional PlacementPRICE SENSITIVE07/05/21 download Created with Sketch. 152.62KB
CMB Grant of Options to CEO and Appendix 3G05/05/21 download Created with Sketch. 368.07KB
CMB Appendix 4C - QuarterlyPRICE SENSITIVE30/04/21 download Created with Sketch. 323.77KB
CMB Regeneus partners with Defence to treat combat casualtiesPRICE SENSITIVE29/04/21 download Created with Sketch. 144KB
CMB Regeneus to be granted key Progenza patent in EuropePRICE SENSITIVE16/03/21 download Created with Sketch. 155.15KB
CMB Regeneus Company Update Investor Webcast PresentationPRICE SENSITIVE03/03/21 download Created with Sketch. 1.16MB
CMB Appendix 3Z Final Director's Interest Notice Dr Alan Dunton01/03/21 download Created with Sketch. 223.48KB
CMB Half-Year Results and Business UpdatePRICE SENSITIVE26/02/21 download Created with Sketch. 166.9KB
CMB Appendix 4D and Half-Year ReportPRICE SENSITIVE26/02/21 download Created with Sketch. 1.13MB
CMB Regeneus Company Update Investor Webcast Notification25/02/21 download Created with Sketch. 138.53KB
CMB Resignation of Non Executive Director Dr Alan Dunton25/02/21 download Created with Sketch. 123.64KB
CMB Regeneus to be granted new patent to target pain in JapanPRICE SENSITIVE09/02/21 download Created with Sketch. 146.19KB
CMB Response to ASX Appendix 4C QueryPRICE SENSITIVE05/02/21 download Created with Sketch. 325.12KB
CMB Clarification on Quarterly Activity Report and Appendix 4C05/02/21 download Created with Sketch. 163KB
CMB Appendix 4C - Quarterly ReportPRICE SENSITIVE29/01/21 download Created with Sketch. 317.22KB
CMB Lapse of Unlisted Share Options19/11/20 download Created with Sketch. 129.35KB
CMB Appendix 3Y - Leo Lee19/11/20 download Created with Sketch. 225.76KB
CMB Appendix 3Y - Alan Dunton19/11/20 download Created with Sketch. 221.31KB
CMB Appendix 3Y - John Chiplin19/11/20 download Created with Sketch. 221.66KB
CMB Appendix 3Y - Graham Vesey19/11/20 download Created with Sketch. 226.31KB
CMB Clarification on Quarterly Activity Report and Appendix 4CPRICE SENSITIVE11/11/20 download Created with Sketch. 123.12KB
CMB Material Terms of Contract for Chief Executive Officer02/11/20 download Created with Sketch. 68.7KB
CMB CEO Appointment and ResignationPRICE SENSITIVE02/11/20 download Created with Sketch. 126KB
CMB Annual Report Additional Information30/10/20 download Created with Sketch. 216.14KB
CMB Appendix 4C - QuarterlyPRICE SENSITIVE30/10/20 download Created with Sketch. 318.66KB
CMB Regeneus receives $5.6M milestone payment from KyoceraPRICE SENSITIVE29/10/20 download Created with Sketch. 122.45KB
CMB Results of Annual General Meeting14/10/20 download Created with Sketch. 126.38KB
CMB AGM Chairman's Address and CEO Presentation14/10/20 download Created with Sketch. 2.14MB
CMB Regeneus to be granted new Sygenus patent in CanadaPRICE SENSITIVE07/10/20 download Created with Sketch. 135.28KB
CMB Australian Biomarker Patent Allowed01/10/20 download Created with Sketch. 136.76KB
CMB Regeneus receives $676k in R&D Tax Incentives29/09/20 download Created with Sketch. 123.14KB
CMB Notice of initial substantial holder - AGC Inc.11/09/20 download Created with Sketch. 118.77KB
CMB Virtual Annual General Meeting Online Guide11/09/20 download Created with Sketch. 717.53KB
CMB Notice of Annual General Meeting / Proxy / Question Form11/09/20 download Created with Sketch. 558.62KB
CMB Issue of AGC shares complete10/09/20 download Created with Sketch. 120.78KB
CMB Appendix 2A10/09/20 download Created with Sketch. 276.06KB
CMB Cleansing Notice10/09/20 download Created with Sketch. 100.45KB
CMB Notice of initial substantial holder - Kirman 2 Pty Ltd08/09/20 download Created with Sketch. 158.72KB
CMB Appendix 3G03/09/20 download Created with Sketch. 278.47KB
CMB Appendix 3Y - Leo Lee03/09/20 download Created with Sketch. 223.88KB
CMB CEO bonus payment03/09/20 download Created with Sketch. 123.19KB
CMB Regeneus receives milestone payment from KyoceraPRICE SENSITIVE28/08/20 download Created with Sketch. 131.33KB
CMB Appendix 4G and Corporate Governance Statement28/08/20 download Created with Sketch. 271.45KB
CMB Appendix 4E and Annual ReportPRICE SENSITIVE28/08/20 download Created with Sketch. 1.51MB
CMB Regeneus to present at FNN Virtual Investor EventPRICE SENSITIVE25/08/20 download Created with Sketch. 1.42MB
CMB US Patent for SygenusPRICE SENSITIVE19/08/20 download Created with Sketch. 137.03KB
CMB Regeneus and Kyocera sign Progenza OA dealPRICE SENSITIVE11/08/20 download Created with Sketch. 184.71KB
CMB Trading HaltPRICE SENSITIVE07/08/20 download Created with Sketch. 147.71KB
CMB Date of AGM05/08/20 download Created with Sketch. 317.18KB
CMB Appendix 4C - QuarterlyPRICE SENSITIVE31/07/20 download Created with Sketch. 300.13KB
CMB Progenza OA Kyocera negotiations updatePRICE SENSITIVE28/07/20 download Created with Sketch. 111.68KB
CMB Appendix 3Z - Final Director's Interest Notice04/06/20 download Created with Sketch. 127.69KB
CMB Director Resignation04/06/20 download Created with Sketch. 121.36KB
CMB Kyocera completes Progenza Due DiligencePRICE SENSITIVE18/05/20 download Created with Sketch. 125.44KB
CMB Appendix 4C UpdatedPRICE SENSITIVE05/05/20 download Created with Sketch. 303.19KB
CMB Appendix 4C - QuarterlyPRICE SENSITIVE29/04/20 download Created with Sketch. 296.66KB
CMB Appendix 3G01/04/20 download Created with Sketch. 272.89KB
CMB Regeneus to be granted new key Progenza patent in U.S.PRICE SENSITIVE23/03/20 download Created with Sketch. 151.7KB
CMB Regeneus receives A$1.6M milestone payment from KyoceraPRICE SENSITIVE20/03/20 download Created with Sketch. 133.92KB
CMB Regeneus signs MOU with Kyocera CorporationPRICE SENSITIVE02/03/20 download Created with Sketch. 158.67KB
CMB Half-Year Results & Business UpdatePRICE SENSITIVE28/02/20 download Created with Sketch. 181.02KB
CMB Appendix 4D and Half-Year ReportPRICE SENSITIVE28/02/20 download Created with Sketch. 1.17MB
CMB Directors provide $4m loan facilityPRICE SENSITIVE28/02/20 download Created with Sketch. 179.4KB
CMB Appendix 3Ys06/02/20 download Created with Sketch. 498.33KB
CMB Appendix 3G06/02/20 download Created with Sketch. 273.92KB
CMB Appendix 4C - QuarterlyPRICE SENSITIVE31/01/20 download Created with Sketch. 313.26KB
CMB Appendix 3G20/01/20 download Created with Sketch. 273.05KB
CMB Proposed issue of Securities - RGS20/12/19 download Created with Sketch. 25.01KB
CMB AGC Agreement termination paves way for commercial partnerPRICE SENSITIVE20/12/19 download Created with Sketch. 172.04KB
CMB RGS receives Innovation Grant18/12/19 download Created with Sketch. 127.26KB
CMB Results of the Annual General Meeting21/11/19 download Created with Sketch. 2.91MB
CMB CEO Presentation to 2019 Annual General MeetingPRICE SENSITIVE21/11/19 download Created with Sketch. 819.25KB
CMB Chairman's Address to ShareholdersPRICE SENSITIVE21/11/19 download Created with Sketch. 66.33KB
CMB Cleansing Statement20/11/19 download Created with Sketch. 92.12KB
CMB Appendix 3B20/11/19 download Created with Sketch. 467.56KB
CMB Japanese Biotech Fund takes up all Rights Issue ShortfallPRICE SENSITIVE19/11/19 download Created with Sketch. 135.62KB
CMB Investor Update Webcast - November 2021
05/11/21 download Created with Sketch. 119.87KB
CMB Amendment to Institutional Placement
05/11/21 download Created with Sketch. 138.3KB
CMB Quarterly Activities/Appendix 4C Cash Flow Report
29/10/21PRICE SENSITIVE download Created with Sketch. 372.82KB
CMB Regeneus Corporate Presentation (October 2021)
28/10/21 download Created with Sketch. 1.31MB
CMB Revised Securities Trading Policy
26/10/21 download Created with Sketch. 225.84KB
CMB Appendix 4G and Corporate Governance Statement
26/10/21 download Created with Sketch. 399.5KB
CMB Annual Report 2021
26/10/21 download Created with Sketch. 6.56MB
CMB Regeneus Company Update Investor Webcast Presentation
25/10/21 download Created with Sketch. 136.6KB
CMB Virtual Annual General Meeting Online Guide
15/10/21 download Created with Sketch. 1.55MB
CMB Notice of Annual General Meeting / Proxy / Question Form
15/10/21 download Created with Sketch. 616.21KB
CMB Application for quotation of securities - RGS
14/10/21 download Created with Sketch. 24.88KB
CMB Cleansing Statement
14/10/21 download Created with Sketch. 681.1KB
CMB Revised Date of AGM
20/09/21 download Created with Sketch. 431.22KB
CMB Appendix 4E - Preliminary final report-unaudited
31/08/21PRICE SENSITIVE download Created with Sketch. 1.04MB
CMB Date of AGM
19/08/21 download Created with Sketch. 432.71KB
CMB Lapse of Unlisted Share Options - correction
09/08/21 download Created with Sketch. 553.51KB
CMB Notification of cessation of securities - RGS
09/08/21 download Created with Sketch. 21.54KB
CMB Lapse of Unlisted Share Options
09/08/21 download Created with Sketch. 124.15KB
CMB Quarterly Activities/Appendix 4C Cash Flow Report
29/07/21PRICE SENSITIVE download Created with Sketch. 320.85KB
CMB R&D Collaboration with Kolling Institute
28/07/21 download Created with Sketch. 309.42KB
CMB Company Secretary Appointment/Resignation
30/06/21 download Created with Sketch. 120.07KB
CMB Appendix 2A
12/05/21 download Created with Sketch. 205.47KB
CMB Cleansing Statement
12/05/21 download Created with Sketch. 95.4KB
CMB Proposed issue of Securities - RGS
07/05/21 download Created with Sketch. 32.58KB
CMB Regeneus Announces Institutional Placement
07/05/21PRICE SENSITIVE download Created with Sketch. 152.62KB
CMB Grant of Options to CEO and Appendix 3G
05/05/21 download Created with Sketch. 368.07KB
CMB Appendix 4C - Quarterly
30/04/21PRICE SENSITIVE download Created with Sketch. 323.77KB
CMB Regeneus partners with Defence to treat combat casualties
29/04/21PRICE SENSITIVE download Created with Sketch. 144KB
CMB Regeneus to be granted key Progenza patent in Europe
16/03/21PRICE SENSITIVE download Created with Sketch. 155.15KB
CMB Regeneus Company Update Investor Webcast Presentation
03/03/21PRICE SENSITIVE download Created with Sketch. 1.16MB
CMB Appendix 3Z Final Director's Interest Notice Dr Alan Dunton
01/03/21 download Created with Sketch. 223.48KB
CMB Half-Year Results and Business Update
26/02/21PRICE SENSITIVE download Created with Sketch. 166.9KB
CMB Appendix 4D and Half-Year Report
26/02/21PRICE SENSITIVE download Created with Sketch. 1.13MB
CMB Regeneus Company Update Investor Webcast Notification
25/02/21 download Created with Sketch. 138.53KB
CMB Resignation of Non Executive Director Dr Alan Dunton
25/02/21 download Created with Sketch. 123.64KB
CMB Regeneus to be granted new patent to target pain in Japan
09/02/21PRICE SENSITIVE download Created with Sketch. 146.19KB
CMB Response to ASX Appendix 4C Query
05/02/21PRICE SENSITIVE download Created with Sketch. 325.12KB
CMB Clarification on Quarterly Activity Report and Appendix 4C
05/02/21 download Created with Sketch. 163KB
CMB Appendix 4C - Quarterly Report
29/01/21PRICE SENSITIVE download Created with Sketch. 317.22KB
CMB Lapse of Unlisted Share Options
19/11/20 download Created with Sketch. 129.35KB
CMB Appendix 3Y - Leo Lee
19/11/20 download Created with Sketch. 225.76KB
CMB Appendix 3Y - Alan Dunton
19/11/20 download Created with Sketch. 221.31KB
CMB Appendix 3Y - John Chiplin
19/11/20 download Created with Sketch. 221.66KB
CMB Appendix 3Y - Graham Vesey
19/11/20 download Created with Sketch. 226.31KB
CMB Clarification on Quarterly Activity Report and Appendix 4C
11/11/20PRICE SENSITIVE download Created with Sketch. 123.12KB
CMB Material Terms of Contract for Chief Executive Officer
02/11/20 download Created with Sketch. 68.7KB
CMB CEO Appointment and Resignation
02/11/20PRICE SENSITIVE download Created with Sketch. 126KB
CMB Annual Report Additional Information
30/10/20 download Created with Sketch. 216.14KB
CMB Appendix 4C - Quarterly
30/10/20PRICE SENSITIVE download Created with Sketch. 318.66KB
CMB Regeneus receives $5.6M milestone payment from Kyocera
29/10/20PRICE SENSITIVE download Created with Sketch. 122.45KB
CMB Results of Annual General Meeting
14/10/20 download Created with Sketch. 126.38KB
CMB AGM Chairman's Address and CEO Presentation
14/10/20 download Created with Sketch. 2.14MB
CMB Regeneus to be granted new Sygenus patent in Canada
07/10/20PRICE SENSITIVE download Created with Sketch. 135.28KB
CMB Australian Biomarker Patent Allowed
01/10/20 download Created with Sketch. 136.76KB
CMB Regeneus receives $676k in R&D Tax Incentives
29/09/20 download Created with Sketch. 123.14KB
CMB Notice of initial substantial holder - AGC Inc.
11/09/20 download Created with Sketch. 118.77KB
CMB Virtual Annual General Meeting Online Guide
11/09/20 download Created with Sketch. 717.53KB
CMB Notice of Annual General Meeting / Proxy / Question Form
11/09/20 download Created with Sketch. 558.62KB
CMB Issue of AGC shares complete
10/09/20 download Created with Sketch. 120.78KB
CMB Appendix 2A
10/09/20 download Created with Sketch. 276.06KB
CMB Cleansing Notice
10/09/20 download Created with Sketch. 100.45KB
CMB Notice of initial substantial holder - Kirman 2 Pty Ltd
08/09/20 download Created with Sketch. 158.72KB
CMB Appendix 3G
03/09/20 download Created with Sketch. 278.47KB
CMB Appendix 3Y - Leo Lee
03/09/20 download Created with Sketch. 223.88KB
CMB CEO bonus payment
03/09/20 download Created with Sketch. 123.19KB
CMB Regeneus receives milestone payment from Kyocera
28/08/20PRICE SENSITIVE download Created with Sketch. 131.33KB
CMB Appendix 4G and Corporate Governance Statement
28/08/20 download Created with Sketch. 271.45KB
CMB Appendix 4E and Annual Report
28/08/20PRICE SENSITIVE download Created with Sketch. 1.51MB
CMB Regeneus to present at FNN Virtual Investor Event
25/08/20PRICE SENSITIVE download Created with Sketch. 1.42MB
CMB US Patent for Sygenus
19/08/20PRICE SENSITIVE download Created with Sketch. 137.03KB
CMB Regeneus and Kyocera sign Progenza OA deal
11/08/20PRICE SENSITIVE download Created with Sketch. 184.71KB
CMB Trading Halt
07/08/20PRICE SENSITIVE download Created with Sketch. 147.71KB
CMB Date of AGM
05/08/20 download Created with Sketch. 317.18KB
CMB Appendix 4C - Quarterly
31/07/20PRICE SENSITIVE download Created with Sketch. 300.13KB
CMB Progenza OA Kyocera negotiations update
28/07/20PRICE SENSITIVE download Created with Sketch. 111.68KB
CMB Appendix 3Z - Final Director's Interest Notice
04/06/20 download Created with Sketch. 127.69KB
CMB Director Resignation
04/06/20 download Created with Sketch. 121.36KB
CMB Kyocera completes Progenza Due Diligence
18/05/20PRICE SENSITIVE download Created with Sketch. 125.44KB
CMB Appendix 4C Updated
05/05/20PRICE SENSITIVE download Created with Sketch. 303.19KB
CMB Appendix 4C - Quarterly
29/04/20PRICE SENSITIVE download Created with Sketch. 296.66KB
CMB Appendix 3G
01/04/20 download Created with Sketch. 272.89KB
CMB Regeneus to be granted new key Progenza patent in U.S.
23/03/20PRICE SENSITIVE download Created with Sketch. 151.7KB
CMB Regeneus receives A$1.6M milestone payment from Kyocera
20/03/20PRICE SENSITIVE download Created with Sketch. 133.92KB
CMB Regeneus signs MOU with Kyocera Corporation
02/03/20PRICE SENSITIVE download Created with Sketch. 158.67KB
CMB Half-Year Results & Business Update
28/02/20PRICE SENSITIVE download Created with Sketch. 181.02KB
CMB Appendix 4D and Half-Year Report
28/02/20PRICE SENSITIVE download Created with Sketch. 1.17MB
CMB Directors provide $4m loan facility
28/02/20PRICE SENSITIVE download Created with Sketch. 179.4KB
CMB Appendix 3Ys
06/02/20 download Created with Sketch. 498.33KB
CMB Appendix 3G
06/02/20 download Created with Sketch. 273.92KB
CMB Appendix 4C - Quarterly
31/01/20PRICE SENSITIVE download Created with Sketch. 313.26KB
CMB Appendix 3G
20/01/20 download Created with Sketch. 273.05KB
CMB Proposed issue of Securities - RGS
20/12/19 download Created with Sketch. 25.01KB
CMB AGC Agreement termination paves way for commercial partner
20/12/19PRICE SENSITIVE download Created with Sketch. 172.04KB
CMB RGS receives Innovation Grant
18/12/19 download Created with Sketch. 127.26KB
CMB Results of the Annual General Meeting
21/11/19 download Created with Sketch. 2.91MB
CMB CEO Presentation to 2019 Annual General Meeting
21/11/19PRICE SENSITIVE download Created with Sketch. 819.25KB
CMB Chairman's Address to Shareholders
21/11/19PRICE SENSITIVE download Created with Sketch. 66.33KB
CMB Cleansing Statement
20/11/19 download Created with Sketch. 92.12KB
CMB Appendix 3B
20/11/19 download Created with Sketch. 467.56KB
CMB Japanese Biotech Fund takes up all Rights Issue Shortfall
19/11/19PRICE SENSITIVE download Created with Sketch. 135.62KB
(20min delay)
Last
40.0¢
Change
0.000(0.00%)
Mkt cap ! $4.772M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 1900 41.0¢
 

Sellers (Offers)

Price($) Vol. No.
50.0¢ 14500 1
View Market Depth
Last trade - 07.00am 17/07/2024 (20 minute delay) ?
CMB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.